2-(Methylthio)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine

Catalog No. :
ACRKYU714
CAS No. :
1011408-19-7
Molecular Formula :
C5H6N6S
Molecular Weight :
182.21

IUPAC Name:2-(methylthio)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine

2-(Methylthio)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$98.00Login to see priceInquiryInquiry
1g95%$214.00Login to see priceInquiryInquiry
5g95%$797.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Methylthio)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine
IUPAC Name2-(methylthio)-[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine
MDL No.MFCD10476962
Molecular FormulaC5H6N6S
Molecular Weight182.21
SMILESNC1=NC=NC2=NC(SC)=NN21
InChI KeyWRSUZSPLQCGVEU-UHFFFAOYSA-N
Synonym2-(METHYLTHIO)[1,2,4]TRIAZOLO[1,5-A][1,3,5]TRIAZIN-7-AMINE;2-(methylthio)[1,2,4]triazolo[1,5-a][1,3,5]triazin-7-amine(SALTDATA: FREE);[1,2,4]Triazolo[1,5-a][1,3,5]triazin-7-amine, 2-(methylthio)-
CAS No.1011408-19-7

Safety Data

Pictogram
CorrosiveHarmful or irritantEnvironmental hazard
Signal Word
Gefahr
Hazard Statement(s)
H302-H318-H410
Precautionary Statement(s)
P273-P280-P301+P312+P330-P305+P351+P338+P310

Synthetic Route by SureRoute

1. ACRKYU714 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRKYU714 route product structure diagram
    ACRKYU7141011408-19-7
Inquiry

2. ACRKYU714 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRXMN357 route compound structure diagram
    ACRXMN3576313-33-3 In Stock
  4. Then
  5. ACRKYU714 route product structure diagram
    ACRKYU7141011408-19-7
Inquiry

Comments (0)